$ALXN News Alexion Pharmaceuticals shares advance 5.3%

New Post Public Reply Private Reply Replies (0) Message Board

Oct 23, 2014 at 1:18 PM

$ALXN News

Alexion Pharmaceuticals shares advance 5.3% 9:32 a.m. Today - Sue Chang
Bed Bath, Starz gain; Citizens Financial debuts 3:52 p.m. Sept. 24, 2014 - Sue Chang
S&P 500 ekes out another record close: stock market live blog recap 4:03 p.m. July 24, 2014 - blogs.marketwatch.com
Biotechs beat estimates, but the Street wants more 11:44 a.m. July 24, 2014 - Russ Britt
22 stocks that may be the gems of earnings season 3:12 a.m. July 10, 2014 - blogs.marketwatch.com
Oracle slides on disappointing results; CarMax soars 4:17 p.m. June 20, 2014 - Sue Chang
Alexion rises 1.4%, among biggest S&P 500 gainers 9:32 a.m. June 6, 2014 - Sue Chang
TripAdvisor leads momentum-play rally to lift Nasdaq 3:52 p.m. May 12, 2014 - Sue Chang
Corner drug store may move overseas to save on taxes 6:31 a.m. April 16, 2014 - Al Lewis
Nasdaq pummeled in worst day since 2011 as tech, biotech cave (Stock market live blog recap) 4:53 p.m. April 10, 2014 - blogs.marketwatch.com
TripAdvisor, Tesla sink as momentum plays lose favor 4:36 p.m. April 10, 2014 - Sue Chang
Biotech hammered as ETFs down 5%, while some stocks fall 10% 1:55 p.m. April 10, 2014 - Russ Britt
Tesla, Facebook, Netflix are Monday’s stocks to watch 5:35 a.m. April 7, 2014 - Sue Chang
Facebook, Tesla slide into bear market territory 4:52 p.m. April 4, 2014 - Sue Chang
Investors continue to pour out of biotech holdings 2:43 p.m. April 4, 2014 - Russ Britt
44 stocks on takeover target radar: Morgan Stanley 12:48 p.m. March 25, 2014 - blogs.marketwatch.com
U.S. stocks fall; Nasdaq skids 1.2% 4:41 p.m. March 24, 2014 - Anora Mahmudova
Apple gains on Comcast talk, new iPhone buzz 4:24 p.m. March 24, 2014 - Sue Chang
First Solar, H-P, Symantec are stocks to watch 4:16 p.m. March 21, 2014 - Sue Chang
First Solar extends winning streak; Symantec plunges 3:07 p.m. March 21, 2014 - Sue Chang

Alexion Pharmaceuticals (ALXN) Q3 2014 Results - Earnings Call Webcast 9:55 a.m. Today - Seeking Alpha
Alexion raises guidance after Q3 results 9:49 a.m. Today - Seeking Alpha
Notable earnings before Thursday’s open 5:30 p.m. Oct. 22, 2014 - Seeking Alpha
Video: Top 4 Earnings Reports To Watch Thursday 2:25 p.m. Oct. 22, 2014 - Investors Business Daily
Biogen Leads 5 Top Biotech Stocks As Earnings Loom 6:56 p.m. Oct. 21, 2014 - Investors Business Daily
Will Alexion (ALXN) Earnings Suffer Due to Higher Costs? - Analyst Blog 5:05 p.m. Oct. 21, 2014 - Zacks.com
Alexion: Keeping Up The Suspense Ahead Of Q3 Earnings 5:01 p.m. Oct. 20, 2014 - Investors Business Daily
End Of The Year Events To Drive Some Of October's Beaten Up Biotech Companies 7:40 a.m. Oct. 20, 2014 - Seeking Alpha
Best U.S. Stock Ideas Today 9:52 a.m. Oct. 17, 2014 - Seeking Alpha
Alexion (ALXN) Seeks Japanese Approval for Asfotase Alfa - Analyst Blog 4:30 p.m. Oct. 16, 2014 - Zacks.com
Analyst Top Biotech Stocks Could Explode After Huge Sell-Off 7:39 a.m. Oct. 16, 2014 - 247WallSt.com
LinkedIn, YY Among 5 Stocks With Top Fundamentals 7:02 a.m. Oct. 16, 2014 - Investors Business Daily
Markets Rebound After Getting Crushed Intraday, Still Close Lower 3:57 p.m. Oct. 15, 2014 - benzinga.com
Alexion submits NDA in Japan for asfotase alfa 7:16 a.m. Oct. 15, 2014 - Seeking Alpha
UBS Very Positive on Top Biotech Stocks Ahead of Earnings 7:58 a.m. Oct. 13, 2014 - 247WallSt.com
Short Interest in Biotech Becomes Company Specific 9:24 a.m. Oct. 10, 2014 - 247WallSt.com
Stock Market News for October 09, 2014 - Market News 10:10 a.m. Oct. 9, 2014 - Zacks.com
Video: 3 Big Cap Biotechs Bucking Market Correction 4:49 p.m. Oct. 8, 2014 - Investors Business Daily
Three Leading Medicals Staying Healthy In Correction 3:36 p.m. Oct. 8, 2014 - Investors Business Daily
Biotech Stock Roundup: Sunesis Tanks on Study Results, Chimerix Up on Ebola Update - Analyst Blog 8:14 a.m. Oct. 8, 2014 - Zacks.com

Collaborations, Dividends, New Drug Applications, and Technical Updates - Research Reports on Simon, Regions Financial, American Capital, CareFusion and Alexion 9:15 a.m. Oct. 21, 2014 - PR Newswire - PRF
Critical Alerts For Sears Holdings, JetBlue, Qlogic, Las Vegas Sands and Alexion Pharmaceuticals Released By InvestorsObserver 9:31 a.m. Oct. 15, 2014 - PR Newswire - PRF
Alexion Submits NDA in Japan for Asfotase Alfa as a Treatment for Patients with Hypophosphatasia 6:30 a.m. Oct. 15, 2014 - BusinessWire - BZX
Alexion Pharmaceuticals to Report Third Quarter 2014 Results on Thursday, October 23, 2014 10:00 a.m. Oct. 9, 2014 - BusinessWire - BZX
Alexion Board of Directors Appoints New Chairman and Creates the New Position of Lead Independent Director 6:30 a.m. Oct. 9, 2014 - BusinessWire - BZX
Alexion Announces the Passing of Max Link, Ph.D., Chairman of the Company’s Board of Directors 4:00 p.m. Oct. 7, 2014 - BusinessWire - BZX
WuXi PharmaTech Announces Appointment of William R. Keller to Board 8:00 a.m. Sept. 30, 2014 - PR Newswire - PRF
Acquisitions, Senior Level Promotions, Public Offering, and Drug Approvals - Research Reports on Acorda, Alexion, Envision, Lilly and Avanir 8:50 a.m. Sept. 29, 2014 - PR Newswire - PRF
Paediatric Patients with Hypophosphatasia Receiving Investigational Asfotase Alfa Had Sustained Improvements in Growth and Physical Function 4:49 a.m. Sept. 19, 2014 - BusinessWire - BZX
Alexion Strengthens and Broadens Its Executive Leadership Team 7:30 a.m. Sept. 17, 2014 - BusinessWire - BZX
Improved Survival Observed in Pediatric Patients with Severe Hypophosphatasia (HPP) Who Were Treated with Investigational Asfotase Alfa for Up to Five Years 5:30 p.m. Sept. 14, 2014 - BusinessWire - BZX
NICE Recommends Commissioning of Eculizumab (Soliris®) for All Patients with aHUS in England 7:01 p.m. Sept. 3, 2014 - BusinessWire - BZX
Technical Updates, Upcoming Conferences, Drug Trials, and Acquisition Updates - Research Reports on SL Green, Allstate, HCA Holdings, Alexion and Salix 9:15 a.m. Sept. 3, 2014 - PR Newswire - PRF
Alexion to Present at Investor Conferences 10:00 a.m. Aug. 28, 2014 - BusinessWire - BZX
Collaborations, Upcoming Seminar, Clinical Trial Results, Data Presentation Schedule - Research Reports on AstraZeneca, Illumina, Novartis, Lilly and Alexion 8:30 a.m. Aug. 26, 2014 - PR Newswire - PRF
Alexion Initiates Multinational Registration Trial of Eculizumab for the Prevention of Delayed Graft Function (DGF) after Kidney Transplantation 6:30 a.m. Aug. 25, 2014 - BusinessWire - BZX
Technical Updates, Study Outcomes, Project Approvals, and Quarterly Performance Reviews - Research Reports on Alexion, Novartis, CB&I, L-3 and Emerson 8:40 a.m. Aug. 15, 2014 - PR Newswire - PRF
Researchers to Present New Data on Asfotase Alfa in Pediatric Patients with Hypophosphatasia at the American Society for Bone and Mineral Research 2014 Annual Meeting 4:57 p.m. Aug. 13, 2014 - BusinessWire - BZX
Cannabis Should Be Treated as an Agricultural Commodity, Not a Biotech Investment 2:44 p.m. Aug. 11, 2014 - ACCESSWIRE
Biotech Equities Technical Momentum -- InterMune, Biogen Idec, Insmed, Dendreon, and Alexion Pharma 8:40 a.m. Aug. 11, 2014 - PR Newswire - PRF

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Catholic Colleges Excel in AI Readiness, Study Shows

Faith and Tech: An Unexpected Alliance? Alright, here's something that'll make you sit up: Catholic college grads are not just busy sipping their morning coffee while they muse over moral philosophy—they're out there on the front lines of artificial intelligence, better prepared and more engaged than their peers from secular schools. According to the latest Holistic...

Money Market Funds Surge to Record $7.98 Trillion

When Money Talks Fast: Market Funds Smash Records Picture this: money market funds have surged to an eye-watering $7.98 trillion. That's a lot of zeros, folks. And it's not just the usual humdrum growth; we're talking a hefty $44.75 billion increase in just one week, thanks to a cocktail of government funds and prime fund muscle, as the Investment Company Institute (ICI)...

Wise Group Investors Alert Ahead of Key Legal Deadline

Sizing Up the Legal Stakes for Wise Group Alright, here's a doozy that's bound to get your attention if you've got a stake in Wise Group plc (NASDAQ: WSE). We're talking about a looming securities class action, with the deadline to get involved barreling down like a runaway freight train. Before September 29, 2026, to be exact—mark it, circle it, do whatever you have to...

Connected Retail Security: Rising Risks and Fragmented Roles

Cyber Threats in the Connected Retail Landscape The retail world isn't what it used to be. Walk into a store today, and you're greeted not just by products but a web of interconnected systems screaming for attention. Sure, you've got your old-school POS systems humming along, but they're just one brittle cog in a rattling machine of IoT devices, cloud platforms, and...

Capricor Faces Lawsuit: Investors Should Take Note

Capricor Therapeutics: A Rough Road Ahead If you've got skin in the game with Capricor Therapeutics, these latest developments might have you feeling a bit queasy. Forget the greasy diner fare today; this situation calls for some serious contemplation and maybe a bit of antacid. Over at NASDAQ:CAPR, the air is hot with allegations, stock price nosedives, and looming legal...

Russo Pushes $100M Boost for Women Entrepreneurs in FL

Russo's Big Bet on Women-led Ventures There's nothing quite like a political shake-up promising to dig into government pockets without slamming taxpayers. Frank Russo, tossing his hat for Florida's governorship, is betting big on women entrepreneurs with a bold move—a $100 million Women’s Entrepreneurship Initiative. No new taxes, he claims, just smart financial...

Clark Pacific's Arizona Plant to Triple Output by 2027

Clark Pacific's Bold Expansion You've got to admire the guts it takes to break new ground, both literally and figuratively. That's exactly what Clark Pacific is doing by launching a spanking new facility in Coolidge, Arizona. It ain't just any plant, either. We're talking about a colossal 110-acre site that'll eventually boost the company's production capacity threefold....

Ed Markey's Political Future on Shaky Ground in MA

Massachusetts Voters Voice Desire for Change Ever seen an old engine stutter and cough before finally quitting? That's what Ed Markey's political career is starting to feel like. A fresh poll has surfaced, casting doubt over his steady grip on his longstanding Senate seat in Massachusetts. People are yearning for fresh faces and new ideas like never before. It's as if the...

University of Phoenix Boosts Networking Strategies

Building Networks: A Key to Professional Growth Listen up, because everyone and their dog is gabbing about mentorship and networking these days—and for good reason. The University of Phoenix is cracking this nut open with their latest webinar, "Build the Network That Advances Your Career: Mentors, Peers & Community," happening on September 17th. They're not just...

Photronics Investors Must Act by Sept. 4, 2026 Deadline

Action Time for Photronics Investors There's nothing like a looming deadline to get the adrenaline pumping, especially when you're staring down the barrel of a federal securities class action. Photronics, Inc. (NASDAQ: PLAB) has found itself tangled in legal webs, with the clock ticking down to September 4, 2026. That’s the deadline for investors to move on being the...